VIM and head and neck squamous cell carcinoma: Therefore, we performed a co-IF with an anti-∝SMA and an anti-vimentin antibody for the two invasively growing 3D-HNSCC-OTC of non-HPV-driven HNSCC (HNSCC1 and HNSCC7) and according primary tumors.